Search research articles
Contact Us
Filters
Showing results (11-20 of 82) with videos related to
Page
of 9
Sort By:
Cancer Treatment Reviews
|
March 2, 2021
The evolving paradigm of biomarker actionability: Histology-agnosticism as a spectrum, rather than a binary quality
Paolo Tarantino, Luca Mazzarella, Antonio Marra, et al.
Human Genomics
|
August 31, 2025
RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity
Emanuele Bonetti, Serena Pellegatta, Nayma Rosati, et al.
Seminars in Hematology
|
October 15, 2014
The genomic and epigenomic landscapes of AML
Luca Mazzarella, Laura Riva, Lucilla Luzi, et al.
Journal of Internal Medicine
|
October 8, 2021
Advances in immune therapies in hematological malignancies
Luca Mazzarella, Gunilla Enblad, Johanna Olweus, et al.
Medical and Pediatric Oncology
|
September 30, 2003
Genetic alterations in hepatoblastoma and hepatocellular carcinoma associated with familial adenomatous polyposis
Francesco Cetta, Luca Mazzarella, Giuseppina Bon, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2020
Master protocols in immuno-oncology: do novel drugs deserve novel designs?
Luca Mazzarella, Stefania Morganti, Antonio Marra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2020
Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity
Luca Mazzarella, Silvia Giugliano, Paolo D'Amico, et al.
Expert Opinion on Investigational Drugs
|
July 19, 2017
Entinostat for the treatment of breast cancer
Dario Trapani, Angela Esposito, Carmen Criscitiello, et al.
Briefings in Bioinformatics
|
September 19, 2024
Clinical bioinformatics desiderata for molecular tumor boards
Matteo Pallocca, Martina Betti, Sara Baldinelli, et al.
Cancers
|
October 16, 2024
The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms
Catarina Almeida, Lorenzo Gervaso, Gianmaria Frigè, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 82) with videos related to
Sort By:
Page
of 9
Cancer Treatment Reviews
|
March 2, 2021
The evolving paradigm of biomarker actionability: Histology-agnosticism as a spectrum, rather than a binary quality
Paolo Tarantino, Luca Mazzarella, Antonio Marra, et al.
Human Genomics
|
August 31, 2025
RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity
Emanuele Bonetti, Serena Pellegatta, Nayma Rosati, et al.
Seminars in Hematology
|
October 15, 2014
The genomic and epigenomic landscapes of AML
Luca Mazzarella, Laura Riva, Lucilla Luzi, et al.
Journal of Internal Medicine
|
October 8, 2021
Advances in immune therapies in hematological malignancies
Luca Mazzarella, Gunilla Enblad, Johanna Olweus, et al.
Medical and Pediatric Oncology
|
September 30, 2003
Genetic alterations in hepatoblastoma and hepatocellular carcinoma associated with familial adenomatous polyposis
Francesco Cetta, Luca Mazzarella, Giuseppina Bon, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2020
Master protocols in immuno-oncology: do novel drugs deserve novel designs?
Luca Mazzarella, Stefania Morganti, Antonio Marra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2020
Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity
Luca Mazzarella, Silvia Giugliano, Paolo D'Amico, et al.
Expert Opinion on Investigational Drugs
|
July 19, 2017
Entinostat for the treatment of breast cancer
Dario Trapani, Angela Esposito, Carmen Criscitiello, et al.
Briefings in Bioinformatics
|
September 19, 2024
Clinical bioinformatics desiderata for molecular tumor boards
Matteo Pallocca, Martina Betti, Sara Baldinelli, et al.
Cancers
|
October 16, 2024
The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms
Catarina Almeida, Lorenzo Gervaso, Gianmaria Frigè, et al.
Page
of 9